Delivery Order SPE2DR25D1113-SPE2DR26FTD0D
- Not listed
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,985,518 units of Dicloxacillin 500 mg capsules. The Delivery Order is valued at $30,770.80 and has a completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating it was awarded...
- The Defense Logistics Agency Troop Support Medical awarded a $265.20 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 capsules of 250mg Dicloxacillin. Amerisourcebergen Drug Corp Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, will fulfill the order from its place of performance in Conshohocken, Pennsylvania between July 13-14, 2023. The delivery order was issued against the Defense Logistics Agency's prime vendor...
- This delivery order against an unspecified contract vehicle was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for one hundred sixty-eight dollars. The order is for one hundred capsules of the antibiotic Dicloxacillin at 250mg per capsule, to be delivered to a location in Conshohocken, Pennsylvania by October 19, 2023. No set-aside designation was applied to this firm fixed price order. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,822.30 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on December 1, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations. This firm fixed-price delivery order, valued at $1,397.53, represents a non-competitive set-aside award and is scheduled for completion by December 2, 2025. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,416.66 to AmerisourceBergen Drug Corp on December 7, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is to be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, with a ceiling value of $3,670.86 and an ultimate completion date of November 7, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp on December 6, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $33,091.38 to AmerisourceBergen Drug Corp on December 1, 2025, with completion targeted for December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $75,646.20 to AmerisourceBergen Drug Corp on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply deliveries. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1113Indefinite Delivery Contract
- SPE2DR25D1113-SPE2DR26FTD0DDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dicloxacillin 250 mg capsules (100-count units) with a contract ceiling value of $1,371.72. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of December 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen's established role as a prime pharmaceutical vendor to the DLA demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and the U.S. Coast Guard through flexible contract vehicles designed to provide essential medications and medical supplies to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/8/25 |